Association for Molecular Pathology
For AMP Webcasts that offer Continuing Education Credit:
Please contact Kathleen Carmody via email with any questions.
Molecular Biomarkers for the Evaluation of Colorectal Cancer
Friday, March 31 at 1:00pm ET
Antonia R. Sepulveda, MD, PhD, Columbia University Medical Center, New York, NY
Anna Yemelyanova, MD, University of Texas MD Anderson Cancer Center, Houston, TX
Training & Education Committee Member
Certificate of Attendance
American Society for Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and American Society of Clinical Oncology (ASCO) have released a new, evidence-based clinical practice guideline on molecular marker testing for patients with colorectal carcinoma that identifies opportunities for improving patient outcomes.
This pivotal guideline addresses a wide range of molecular markers appropriate for testing in patients with early and advanced colorectal cancer. This guideline will aid in establishing standard molecular marker testing to help guide targeted therapy decisions, and advance personalized care for colorectal cancer patients.
Number of Contact hours: 1.0
Level of Instruction: Basic